TKTL1 and kidney cancer: Through cell viability assays and cell colony formation experiments, it was found that piperine and glibenclamide can effectively agonize the activity of TKTL1, indicating that small molecule drugs of kinase agonists may play a role in tumor treatment, achieving drug repositioning and providing novel ideas for kidney cancer treatment (Figure 8).